Recent Finacing
Recent Raise
Comet Therapeutics develops drugs using its CoMET™ platform to target specific CoA species to diseased tissues and organelles, advancing a pipeline for metabolic, neuro‑metabolic, and immuno‑metabolic conditions.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at Comet Therapeutics.
